PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsMenthol
Menthol
Salonpas (menthol) is a small molecule pharmaceutical. Menthol was first approved as Salonpas on 2008-02-20. It is used to treat pain and skin diseases in the USA. The pharmaceutical is active against alpha-1A adrenergic receptor, alpha-2A adrenergic receptor, and transient receptor potential cation channel subfamily M member 8. In addition, it is known to target alpha-2B adrenergic receptor, 5-hydroxytryptamine receptor 1B, 5-hydroxytryptamine receptor 1D, transient receptor potential cation channel subfamily A member 1, alpha-1B adrenergic receptor, 5-hydroxytryptamine receptor 2C, transient receptor potential cation channel subfamily V member 3, alpha-2C adrenergic receptor, and alpha-1D adrenergic receptor.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
skin and connective tissue diseasesD017437
signs and symptoms pathological conditionsD013568
psychological phenomenaD011579
musculoskeletal and neural physiological phenomenaD055687
Trade Name
FDA
EMA
Combinations
Salonpas
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Menthol
+
Methyl salicylate
Tradename
Company
Number
Date
Products
SALONPASHisamitsu PharmaceuticalN-022029 OTC2008-02-20
2 products, RLD, RS
Labels
FDA
EMA
Brand Name
Status
Last Update
air sinsinpas-exC2002632024-01-05
antiphlamineunapproved drug other2017-05-11
cool pap cataplasmaOTC monograph not final2022-01-17
essentialsOTC monograph not final2018-12-21
family care pain reliefOTC monograph not final2013-11-26
hallsC2002632024-12-20
halls naturalsOTC monograph final2013-08-07
hallsmelon splashOTC monograph final2014-02-04
hallssugar free extraOTC monograph not final2014-02-07
mentholatumunapproved drug other2023-07-06
Show 17 more
Agency Specific
FDA
EMA
No data
Patent Expiration
Patent
Expires
Flag
FDA Information
Menthol / Methyl Salicylate, Salonpas, Hisamitsu Pharm Co
88096152030-01-03DP
92331842027-08-01DP
ATC Codes
No data
HCPCS
No data
Clinical
No data
Drug
General
Drug common nameMenthol
INNracementhol
Description
(-)-menthol is a p-menthan-3-ol which has (1R,2S,5R)-stereochemistry. It is the most common naturally occurring enantiomer. It has a role as an antipruritic drug, an antitussive and an antispasmodic drug. It is an enantiomer of a (+)-menthol.
Classification
Small molecule
Drug class
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
CC1CCC(C(C)C)C(O)C1
Identifiers
PDB
CAS-ID114376-98-6
RxCUI
ChEMBL IDCHEMBL256087
ChEBI ID25187
PubChem CID16666
DrugBankDB00825
UNII IDYS08XHA860 (ChemIDplus, GSRS)
Target
Agency Approved
ADRA1A
ADRA1A
ADRA2A
ADRA2A
TRPM8
TRPM8
Organism
Homo sapiens
Gene name
ADRA1A
Gene synonyms
ADRA1C
NCBI Gene ID
Protein name
alpha-1A adrenergic receptor
Protein synonyms
Alpha-1A adrenoceptor, Alpha-1A adrenoreceptor, Alpha-1C adrenergic receptor, Alpha-adrenergic receptor 1c, G protein coupled receptor
Uniprot ID
Mouse ortholog
Adra1a (11549)
alpha-1A adrenergic receptor (Q8BV77)
Alternate
ADRA2B
ADRA2B
HTR1B
HTR1B
HTR1D
HTR1D
TRPA1
TRPA1
ADRA1B
ADRA1B
HTR2C
HTR2C
TRPV3
TRPV3
ADRA2C
ADRA2C
ADRA1D
ADRA1D
Organism
Homo sapiens
Gene name
ADRA2B
Gene synonyms
ADRA2L1, ADRA2RL1
NCBI Gene ID
Protein name
alpha-2B adrenergic receptor
Protein synonyms
ADRA2B adrenergic, alpha-2B-, receptor, Alpha-2 adrenergic receptor subtype C2, alpha-2-adrenergic receptor-like 1, Alpha-2B adrenoceptor, Alpha-2B adrenoreceptor, Alpha-2BAR, G-protein coupled receptor
Uniprot ID
Mouse ortholog
Adra2b (11552)
alpha-2B adrenergic receptor (P30545)
Variants
No data
Financial
Revenue by drug
$
£
No data
Estimated US medical usage
Menthol
+
Benzocaine
Total medical expenditures per year (USD, in millions)
Plot placeholder
Mock data
Subscribe for the real data
Number of persons purchased
Plot placeholder
Mock data
Subscribe for the real data
Number of purchases
Plot placeholder
Mock data
Subscribe for the real data
Refill frequency
Plot placeholder
Mock data
Subscribe for the real data
Price per prescription (USD)
Plot placeholder
Mock data
Subscribe for the real data
Menthol
Total medical expenditures per year (USD, in millions)
Plot placeholder
Mock data
Subscribe for the real data
Number of persons purchased
Plot placeholder
Mock data
Subscribe for the real data
Number of purchases
Plot placeholder
Mock data
Subscribe for the real data
Refill frequency
Plot placeholder
Mock data
Subscribe for the real data
Price per prescription (USD)
Plot placeholder
Mock data
Subscribe for the real data
Menthol
+
Methyl salicylate
Total medical expenditures per year (USD, in millions)
Plot placeholder
Mock data
Subscribe for the real data
Number of persons purchased
Plot placeholder
Mock data
Subscribe for the real data
Number of purchases
Plot placeholder
Mock data
Subscribe for the real data
Refill frequency
Plot placeholder
Mock data
Subscribe for the real data
Price per prescription (USD)
Plot placeholder
Mock data
Subscribe for the real data
Tabular view
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
0 adverse events reported
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use